<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31204557</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling.</ArticleTitle><Pagination><StartPage>548</StartPage><EndPage>561</EndPage><MedlinePgn>548-561</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2019.1632104</ELocationID><Abstract><AbstractText>Glucosamine (GlcN), a dietary supplement widely utilized to promote joint health and effective in the treatment of osteoarthritis, is an effective macroautophagy/autophagy activator <i>in vitro</i> and <i>in vivo</i>. Previous studies have shown that autophagy is required for hepatitis B virus (HBV) replication and envelopment. The objective of this study was to determine whether and how GlcN affects HBV replication, using <i>in vitro</i> and <i>in vivo</i> experiments. Our data demonstrated that HBsAg production and HBV replication were significantly increased by GlcN treatment. Confocal microscopy and western blot analysis showed that the amount of autophagosomes and the levels of autophagic markers MAP1LC3/LC3-II and SQSTM1 were clearly elevated by GlcN treatment. GlcN strongly blocked autophagic degradation of HBV virions and proteins by inhibiting lysosomal acidification through its amino group. Moreover, GlcN further promoted HBV replication by inducing autophagosome formation via feedback inhibition of mechanistic target of rapamycin kinase complex 1 (MTORC1) signaling in an RRAGA (Ras related GTP binding A) GTPase-dependent manner. <i>In vivo</i>, GlcN application promoted HBV replication and blocked autophagic degradation in an HBV hydrodynamic injection mouse model. In addition, GlcN promoted influenza A virus, enterovirus 71, and vesicular stomatitis virus replication <i>in vitro</i>. In conclusion, GlcN efficiently promotes virus replication by inducing autophagic stress through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling. Thus, there is a potential risk of enhanced viral replication by oral GlcN intake in chronically virally infected patients.<b>Abbreviations</b>: ACTB: actin beta; ATG: autophagy-related; CMIA: chemiluminescence immunoassay; ConA: concanavalin A; CQ: chloroquine; CTSD: cathepsin D; DAPI: 4',6-diamidino-2-phenylindole; EV71: enterovirus 71; GalN: galactosamine; GFP: green fluorescence protein; GlcN: glucosamine; GNPNAT1: glucosamine-phosphate N-acetyltransferase 1; HBP: hexosamine biosynthesis pathway; HBV: hepatitis B virus; HBcAg: hepatitis B core antigen; HBsAg: hepatitis B surface antigen; HBeAg: hepatitis B e antigen; HBV RI: hepatitis B replicative intermediate; IAV: influenza A virus; LAMP1: lysosomal associated membrane protein 1; LAMTOR: late endosomal/lysosomal adaptor, MAPK and MTOR activator; ManN: mannosamine; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MTORC1: mechanistic target of rapamycin kinase complex 1; PHH: primary human hepatocyte; RAB7: RAB7A, member RAS oncogene family; RPS6KB1: ribosomal protein S6 kinase B1; RRAGA: Ras related GTP binding A; RT-PCR: reverse transcriptase polymerase chain reaction; SEM: standard error of the mean; siRNA: small interfering RNA; SQSTM1/p62: sequestosome 1; UAP1: UDP-N-acetylglucosamine pyrophosphorylase 1; VSV: vesicular stomatitis virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9171-0195</Identifier><AffiliationInfo><Affiliation>Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Key Laboratory of Molecular Biology of Infectious Diseases designated by the Chinese Ministry of Education, Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chunchen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xueyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Kaitao</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kemper</LastName><ForeName>Thekla</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haisheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mingzhou</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xinwen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mengji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>N08U5BOQ1K</RegistryNumber><NameOfSubstance UI="D005944">Glucosamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005944" MajorTopicYN="N">Glucosamine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057446" MajorTopicYN="N">Hydrodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018116" MajorTopicYN="N">Vesiculovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autophagy</Keyword><Keyword MajorTopicYN="N">HBV</Keyword><Keyword MajorTopicYN="N">MTORC1 signaling</Keyword><Keyword MajorTopicYN="N">glucosamine</Keyword><Keyword MajorTopicYN="N">lysosomal acidification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31204557</ArticleId><ArticleId IdType="pmc">PMC6999643</ArticleId><ArticleId IdType="doi">10.1080/15548627.2019.1632104</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Skarbek K, Milewska MJ.. Biosynthetic and synthetic access to amino sugars. Carbohydr Res. 2016;434:44&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">27592039</ArticleId></ArticleIdList></Reference><Reference><Citation>Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">11214126</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin R, Cousins G, Boland F, et al. Prescribing patterns of glucosamine in an older population: a national cohort study. BMC Complement Altern Med. 2013;13:316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3874622</ArticleId><ArticleId IdType="pubmed">24219123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahedipour F, Dalirfardouei R, Karimi G, et al. Molecular mechanisms of anticancer effects of Glucosamine. Biomed Pharmacother. 2017;95:1051&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">28922722</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Machado GC, Eyles JP, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52:167&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">29018060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahim V, Albeldawi M, Chiang DJ.. Acute liver injury associated with glucosamine dietary supplement. BMJ Case Rep. 2012;2012:bcr2012007665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544092</ArticleId><ArticleId IdType="pubmed">23239775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerda C, Bruguera M, Pares A. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J Gastroenterol. 2013;19:5381&#x2013;5384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752575</ArticleId><ArticleId IdType="pubmed">23983444</ArticleId></ArticleIdList></Reference><Reference><Citation>Denzel MS, Storm NJ, Gutschmidt A, et al. Hexosamine pathway metabolites enhance protein quality control and prolong life. Cell. 2014;156:1167&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">24630720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong H, Lindsten T, Wu J, et al. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A. 2011;108:11121&#x2013;11126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131371</ArticleId><ArticleId IdType="pubmed">21690395</ArticleId></ArticleIdList></Reference><Reference><Citation>Carames B, Kiosses WB, Akasaki Y, et al. Glucosamine activates autophagy in vitro and in vivo. Arthritis Rheum. 2013;65:1843&#x2013;1852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772083</ArticleId><ArticleId IdType="pubmed">23606170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Jin Y, Wang H, et al. Glucosamine protects nucleus pulposus cells and induces autophagy via the mTOR-dependent pathway. J Orthop Res. 2014;32:1532&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pubmed">25087910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Orvedahl A, MacPherson S, Sumpter R Jr., et al. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe. 2010;7:115&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860265</ArticleId><ArticleId IdType="pubmed">20159618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding B, Zhang G, Yang X, et al. Phosphoprotein of human parainfluenza virus type 3 blocks autophagosome-lysosome fusion to increase virus production. Cell Host Microbe. 2014;15:564&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">24832451</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Lababidi RR, Hadj SB, et al. Activation of Nrf2 signaling augments vesicular stomatitis virus oncolysis via autophagy-driven suppression of antiviral immunity. Mol Ther. 2017;25:1900&#x2013;1916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542709</ArticleId><ArticleId IdType="pubmed">28527723</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Feng C, Tian X, et al. Promyelocytic leukemia restricts enterovirus 71 replication by inhibiting autophagy. Front Immunol. 2018;9:1268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996053</ArticleId><ArticleId IdType="pubmed">29922292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeganeh B, Ghavami S, Rahim MN, et al. Autophagy activation is required for influenza A virus-induced apoptosis and replication. Biochim Biophys Acta. 2018;1865:364&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">29108912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sir D, Tian YJ, Chen WL, et al. The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication. Proc Natl Acad Sci U S A. 2010;107:4383&#x2013;4388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840127</ArticleId><ArticleId IdType="pubmed">20142477</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liu Y, Wang Z, et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J Virol. 2011;85:6319&#x2013;6333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126540</ArticleId><ArticleId IdType="pubmed">21507968</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64:S4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4834849</ArticleId><ArticleId IdType="pubmed">27084035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang LSY, Covert E, Wilson E, et al. Chronic hepatitis B infection: a review. JAMA. 2018;319:1802&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pubmed">29715359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan SH, Wu SY, Zuchini R, et al. Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology. 2014;59:505&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298796</ArticleId><ArticleId IdType="pubmed">23913306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Deng W, Pang J, et al. The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy. Cell Microbiol. 2017;19:e12709.</Citation><ArticleIdList><ArticleId IdType="pubmed">27886437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Wu C, Wang X, et al. Hepatitis B virus is degraded by autophagosome-lysosome fusion mediated by Rab7 and related components. Protein Cell. 2019;10:60&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6321816</ArticleId><ArticleId IdType="pubmed">29876903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Wu C, Wang X, et al. Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus. Faseb J. 2019;33:6023&#x2013;6034.</Citation><ArticleIdList><ArticleId IdType="pubmed">30742775</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B, Liang Q, Li L, et al. O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation. Nat Cell Biol. 2014;16:1215&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pubmed">25419848</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Zhou X, Pendleton KE, et al. A conserved splicing silencer dynamically regulates O-GlcNAc transferase intron retention and O-GlcNAc homeostasis. Cell Rep. 2017;20:1088&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588854</ArticleId><ArticleId IdType="pubmed">28768194</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini P, Strambi A, Zipoli C, et al. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies. Autophagy. 2014;10:562&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984580</ArticleId><ArticleId IdType="pubmed">24492472</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Fang M, Hu Y, et al. Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation. Autophagy. 2014;10:416&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077881</ArticleId><ArticleId IdType="pubmed">24401568</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Khambu B, Zhang H, et al. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem. 2013;288:35769&#x2013;35780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861628</ArticleId><ArticleId IdType="pubmed">24174532</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton PT, Vuppalapati KK, Bouderlique T, et al. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner. Autophagy. 2015;11:1594&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590675</ArticleId><ArticleId IdType="pubmed">26259639</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shintani T, Yamazaki F, Katoh T, et al. Glucosamine induces autophagy via an mTOR-independent pathway. Biochem Biophys Res Commun. 2010;391:1775&#x2013;1779.</Citation><ArticleIdList><ArticleId IdType="pubmed">20045674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YH, Nakayama T, Nayak J. Glycolysis and the hexosamine biosynthetic pathway as novel targets for upper and lower airway inflammation. Allergy Asthma Immunol Res. 2018;10:6&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5705485</ArticleId><ArticleId IdType="pubmed">29178672</ArticleId></ArticleIdList></Reference><Reference><Citation>Seglen PO, Reith A. Ammonia inhibition of protein degradation in isolated rat hepatocytes quantitative ultrastructural alterations in the lysosomal system. Exp Cell Res. 1976;100:276&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">939253</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng CH, Yu K, Lucas J, et al. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal. 2010;3:ra31.</Citation><ArticleIdList><ArticleId IdType="pubmed">20424262</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoncu R, Bar-Peled L, Efeyan A, et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 2011;334:678&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211112</ArticleId><ArticleId IdType="pubmed">22053050</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZW, Li ZL, Yuan S. The role of secretory autophagy in Zika virus transfer through the placental barrier. Front Cell Infect Microbiol. 2016;6:206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5220013</ArticleId><ArticleId IdType="pubmed">28119857</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SA, Hu J. Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention. Emerg Microbes Infect. 2013;2:e56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820986</ArticleId><ArticleId IdType="pubmed">26038488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Yang B, Cao H, et al. RBM24 stabilizes hepatitis B virus pregenomic RNA but inhibits core protein translation by targeting the terminal redundancy sequence. Emerg Microbes Infect. 2018;7:86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951808</ArticleId><ArticleId IdType="pubmed">29760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Yang B, Chen Y, et al. RNA-binding motif protein 24 (RBM24) is involved in pgRNA packaging by mediating interaction between HBV polymerase and the epsilon element. J Virol. 2019;93:e02161-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401439</ArticleId><ArticleId IdType="pubmed">30626666</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie N, Yuan KF, Zhou L, et al. PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation. Autophagy. 2016;12:1507&#x2013;1520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5082782</ArticleId><ArticleId IdType="pubmed">27305174</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue J, Krueger EW, Chen J, et al. HBV secretion is regulated through the activation of endocytic and autophagic compartments mediated by Rab7 stimulation. J Cell Sci. 2015;128:1696&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4446738</ArticleId><ArticleId IdType="pubmed">25770103</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang B, Himmelsbach K, Ren H, et al. Subviral hepatitis B virus filaments, like infectious viral particles, are released via multivesicular bodies. J Virol. 2015;90:3330&#x2013;3341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4794700</ArticleId><ArticleId IdType="pubmed">26719264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Huang X, Wu J, et al. Pre-activation of toll-like receptor 2 enhances CD8(+) T-cell responses and accelerates hepatitis B virus clearance in the mouse models. Front Immunol. 2018;9:1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6033958</ArticleId><ArticleId IdType="pubmed">30008718</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmbeck R, Bohm W, Ando K, et al. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol. 1995;69:5929&#x2013;5934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189487</ArticleId><ArticleId IdType="pubmed">7666497</ArticleId></ArticleIdList></Reference><Reference><Citation>Carman WF, Van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology. 1997;26:1658&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pubmed">9398013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Deng W, Deng L, et al. Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol. 2012;86:4658&#x2013;4669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3318601</ArticleId><ArticleId IdType="pubmed">22301154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang E, Ma Z, et al. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology. 2011;53:1476&#x2013;1485.</Citation><ArticleIdList><ArticleId IdType="pubmed">21520166</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y, Cao W, Han T, et al. Inducible Rubicon facilitates viral replication by antagonizing interferon production. Cell Mol Immunol. 2017;14:607&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520414</ArticleId><ArticleId IdType="pubmed">28392573</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Hao Q, Peng N, et al. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology. 2012;56:57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">22318991</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Z, Xu Y, Wu J, et al. Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J Virol Methods. 2008;150:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112819</ArticleId><ArticleId IdType="pubmed">18378325</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Zou S, Chen M, et al. Local stimulation of liver sinusoidal endothelial cells with a NOD1 agonist activates T cells and suppresses hepatitis B virus replication in mice. J Immunol. 2018;200:3170&#x2013;3179.</Citation><ArticleIdList><ArticleId IdType="pubmed">29592964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>